Home › Ulcerative Colitis › Kansas › Kansas City
Ulcerative Colitis clinical trials in Kansas City, KS
5 studies for Ulcerative Colitis are looking for participants at sites in and around Kansas City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
RecruitingPhase 1
- University of Kansas Cancer Center, Kansas City
A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)
RecruitingPhase 2
- University of Kansas Medical Center ( Site 1077), Kansas City
A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
RecruitingPhase 2
- University of Kansas Medical Center, Kansas City
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
RecruitingPhase 2
- Site 006, Kansas City
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
RecruitingPhase 3
- University of Kansas Medical Center - Site Number: 8400110, Kansas City
About Ulcerative Colitis
Ulcerative Colitis (UC) can cause long-lasting swelling and ulcers in the large intestine. It is a type of inflammatory bowel disease. Find out more.
More about Ulcerative Colitis on MedlinePlus
Ulcerative Colitis trials in other cities
- Orlando, FL21 studies
- New York City, NY21 studies
- Miami, FL20 studies
- Houston, TX14 studies
- San Diego, CA13 studies
- Chicago, IL13 studies
- Tacoma, WA13 studies
- St. Louis, MO13 studies
- Tyler, TX13 studies
- San Antonio, TX13 studies
- Colorado Springs, CO12 studies
- Boston, MA12 studies
Other studies in Kansas City
- Interstitial Lung Diseases13 studies
- Obesity13 studies
- Cystic Fibrosis13 studies
- Acute Myeloid Leukemia12 studies
- Prostate Cancer12 studies
- Heart Failure12 studies
- Non-Small Cell Lung Cancer12 studies
- Cardiovascular Disease12 studies
- Breast Cancer12 studies
- Lung Cancer11 studies
- Bladder Cancer10 studies
- Asthma9 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.